Palabras clave
Dolor de cabeza
Alimentación
Suplementación nutricional
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar los principales artículos disponibles sobre el impacto que la suplementación con micronutrientes y los cambios dietéticos tiene en los pacientes con migraña. Revisión de la literatura: La migraña es una enfermedad neurológica crónica cuya fisiopatología aún no se comprende del todo, aunque se conoce la presencia de citocinas inflamatorias y desequilibrios iónicos. Como tratamiento alternativo o complementario al tratamiento tradicional, la suplementación con magnesio, isoflavonas de soja, nanocurcumina, omega 3 solos o en combinación con nancurcumina, zinc, ácido lipoico y vitamina D fueron beneficiosos para los pacientes con migraña. Además, los cambios dietéticos que aumentan el consumo de ácidos grasos n-3 y los disminuyen los ácidos grasos n-6 la y la dieta cetogénica también tuvieron resultados favorables en la frecuencia y duración de los ataques de migraña. Consideraciones finales: La migraña es una enfermedad neurológica ampliamente extendida a nivel mundial, con fisiopatología y tratamiento complejos. Varios factores pueden influir en su manifestación, e intervenciones como la suplementación con micronutrientes y los cambios en la dieta pueden ser eficaces para mejorar las perspectivas y la calidad de vida de los pacientes, sin causar efectos secundarios. Por tanto, es fundamental que los profesionales sanitarios evalúen individualmente a cada paciente con migraña para poder proporcionar un tratamiento eficaz y un pronóstico favorable.
Referencias
ABDOLAHI M, et al. The omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial. BMC Research Notes. 2021;14(1).
AHMADI H, et al. Zinc supplementation affects favorably the frequency of migraine attacks: a double-blind randomized placebo-controlled clinical trial. Nutrition Journal. 2020;19 (1).
AKBARI M, et al. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutrition & Metabolism. 2018; 15 (1).
ALTUNKAYNAK Y, et al. Serum lactic acid and pyruvic acid levels in patients with migraine and tension type headache. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. 2013; 276–80.
ATTERITANO M, et al. Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study. Osteoporosis International. 2013; 25(3):1123–9.
BABAPOUR M, et al. Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomised controlled trial. Nutrition Journal. 2022; 21(1).
BOSKA MD, et al. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology. 2002; 58(8):1227–33.
CAPRIO M, et al. Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial. Journal of Translational Medicine. 2023; 21(1).
CEGIELSKA J, et al. Migraine and Its Association with Hyperactivity of Cell Membranes in the Course of Latent Magnesium Deficiency—Preliminary Study of the Importance of the Latent Tetany Presence in the Migraine Pathogenesis. Nutrients. 2021; 13(8):2701.
CHEN D. Analysis of omega-3 and omega-6 polyunsaturated fatty acid metabolism by compound-specific isotope analysis in humans. Jorunal of lipid research. 2023.
Di LORENZO C, et al. A Randomized Double-Blind, Cross-Over Trial of very Low-Calorie Diet in Overweight Migraine Patients: A Possible Role for Ketones? Nutrients. 2019; 11(8):1742.
GHORBANi Z, et al. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. The Journal of Headache and Pain. 2020; 21(1).
GHORBANI Z, et al. Vitamin D in migraine headache: a comprehensive review on literature. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2019; 40(12):2459–77.
GONULLU H, et al. The levels of trace elements and heavy metals in patients with acute migraine headache. JPMA The Journal of the Pakistan Medical Association. 2015; 65(7):694–7.
GROSS EC, et al. Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers. Scientific Reports. 2023; 13(1).
GROSS EC, et al. Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine. Scientific Reports. 2021; 11(1):4543.
IKEDA A, et al. Resolvin D1 suppresses inflammation-induced hyperexcitability of nociceptive trigeminal neurons associated with mechanical hyperalgesia. Brain Research Bulletin. 2020 Jan 1; 154:61–7.
JAROSZ M, et al. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology. 2017; 25(1):11–24.
KELISHADI MR, et al. The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines. Scientific Reports. 2022; 12(1).
LI H, et al. Leukocyte inflammatory phenotype and function in migraine patients compared with matched non-migraine volunteers: a pilot study. BMC neurology. 2022; 22(1).
MACINTOSH B. Methodology for altering omega-3 EPA+DHA and omega-6 linoleic acid as controlled variables in a dietary trial. Clinical Nutrition. 2021.
MAYANS L, WALLING A. Acute Migraine Headache: Treatment Strategies. American Family Physician. 2018; 97(4):243–51.
MEßLINGER K. Bedeutung des, calcitonin gene-related peptide“ (CGRP) in der Pathophysiologie von Migräne und Clusterkopfschmerz. Der Schmerz. 2020; 34(2):181–7.
OLESEN J. Understanding the Biologic Basis of Migraine. New England Journal of Medicine. 1994; 331(25):1713–4.
RAMSDEN CE, et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial. BMJ. 2021; 374:n1448.
RAMSDEN CE, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial. Pain. 2013; 154(11):2441–51.
SAN MAURO MARTIN I, et al. Effects of Gluten on Gut Microbiota in Patients with Gastrointestinal Disorders, Migraine, and Dermatitis. Nutrients. 2024; 16(8):1228.
SEDIGHIYAN M, et al. The effects of nano-curcumin supplementation on adipokines levels in obese and overweight patients with migraine: a double blind clinical trial study. BMC Research Notes. 2022;15(1).
VINOGRADOVA LV. Initiation of spreading depression by synaptic and network hyperactivity: Insights into trigger mechanisms of migraine aura. Cephalalgia. 2017; 38(6):1177–87.
WANG HF, et al. A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine. Brain, Behavior, and Immunity. 2024;118:459–67.
ZIS P, et al. Headache Associated with Coeliac Disease: A Systematic Review and Meta-Analysis. Nutrients. 2018; 10(10):1445.